A Comparative Study of Apigenin Content and Antioxidant Potential of Cosmos Bipinnatus Transgenic Root Culture
Publish place: Pharmaceutical and Biomedical Research، Vol: 7، Issue: 2
Publish Year: 1399
نوع سند: مقاله ژورنالی
زبان: English
View: 60
This Paper With 10 Page And PDF Format Ready To Download
- Certificate
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_PBRE-7-2_003
تاریخ نمایه سازی: 10 دی 1402
Abstract:
Background: Flavonoid-derived components have been studied for their therapeutic properties.
Objectives: Apigenin has shown remarkable antioxidant and anti-inflammatory features, so we should have a reliable source of apigenin.
Methods: In this study, we used high-performance liquid chromatography method to compare the amount of apigenin in flower, root, leaf, and stem of three varieties of osmos bipinnatus, i.e., ‘Dazzler,’ ‘Xanthos,’ ‘Sensation Pinkie’, and in transgenic root culture of C. bipinnatus ‘Dazzler’. Besides, the antioxidant activity of C. bipinnatus ‘Dazzler’ transgenic root culture was evaluated using Ferric Reducing Antioxidant Power (FRAP) assay.
Results: Dazzler variety flowers showed the highest recovery of apigenin with ۰.۷۹۹ mg/۱۰۰ mg Dry Weight (DW). However, the Sensation pinkie variety leafs had the lowest recovery with ۰.۰۸۹ mg/۱۰۰mg. Apigenin content in transformed roots (۰.۷۹۷ mg/۱۰۰ mg DW) of C. bipinnatus ‘Dazzler’ was significantly higher than non-transformed roots (۰.۴۲ mg/۱۰۰ mg DW). The ethanolic extract of hairy root showed the FRAP value of ۶۶۸.۱ µM Fe۲+/mg that was comparatively more than the wild root FRAP value (۴۲۶.۲ µM Fe۲+/mg).
Conclusion: In conclusion, the presence of apigenin in high amounts in hairy root cultures of C. bipinnatus ‘Dazzler’ indicates its great potential for the future pharmaceutical industry.
Keywords:
Authors
Soroush Bijani
Zanjan Pharmaceutical Biotechnology Research Center, Zanjan University of Medical Sciences, Zanjan, Iran.
Zahra Gharari
Department of Plant Production and Genetics, Faculty of Agriculture, University of Zanjan, Zanjan, Iran.
Alireza Ahmadnia
Zanjan Pharmaceutical Biotechnology Research Center, Zanjan University of Medical Sciences, Zanjan, Iran.
Hossein Danafar
Department of Pharmaceutical Biotechnology, School of Pharmacy, Zanjan University of Medical Sciences, Zanjan, Iran.
Ali Sharafi
Zanjan Pharmaceutical Biotechnology Research Center, Zanjan University of Medical Sciences, Zanjan, Iran.
مراجع و منابع این Paper:
لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :